Market Place
Sourcing Support
Beta blocker treatment paradigm shifts for myocardial infarction
03 Sep 2024 //
PHARMACEUTICAL TECHNOLOGY
Hospira Inc. Issues A Voluntary Nationwide Recall For Buprenorphine HCL
22 May 2024 //
FDA
Enforcement Report - Week of August 24, 2022
24 Aug 2022 //
FDA
Unichem Lab`s Generic Labetalol Hydrochloride Receives Approval in the U.S.
08 Aug 2022 //
FDA
Caplin Steriles gets USFDA approval for Labetalol Hydrochloride injection USP
08 Sep 2021 //
PHARMABIZ
Caplin`s Generic Labetalol Hydrochloride Receives Approval in the US
07 Sep 2021 //
FDA
Rubicon`s Generic Labetalol HCl Receives Approval In the US
20 Aug 2021 //
FDA
Epic Pharma Llc`s Generic Labetalol Hydrochloride Receives Approval In US
30 Sep 2020 //
FDA
Cadila Pharms Generic Labetalol Hydrochloride Receives Approval in US
16 May 2019 //
FDA
Enforcement Report - Week of May 1, 2019
01 May 2019 //
FDA
Enforcement Report for Week of February 20, 2019
20 Feb 2019 //
FDA
Invatech`s Generic Labetalol Hydrochloride Receives Approval in US
04 Feb 2019 //
FDA
Appco Pharma’s Generic Labetalol Hydrochloride Receives Approval In US
26 Jun 2018 //
FDA
Enforcement Report - Week of March 14, 2018
14 Mar 2018 //
FDA
Enforcement Report - Week of February 28, 2018
28 Feb 2018 //
FDA
Zydus Pharm’s Generic Labetalol Hydrochloride Receives Approval In US
21 Sep 2017 //
FDA
Hospira recalls injected dextrose for infants
31 May 2017 //
FIERCE PHARMA
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.